ArticleGlobal & regional health technology assessment

Cost analysis of extended half-life recombinant factor IX products in the treatment of haemophilia B in Italy: an update.

Andrea Aiello et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.